Analysts at Piper Jaffray downgraded Vitamin Shoppe VSI from Overweight to Neutral. The target price for Vitamin Shoppe has been lowered from $45 to $44. Vitamin Shoppe's shares closed at $45.40 yesterday.
Analysts at RBC Capital downgraded Athlon Energy ATHL from Outperform to Sector Perform. The target price for Athlon Energy has been raised from $55 to $59. Athlon Energy's shares closed at $58.32 yesterday.
Analysts at Bank of America downgraded Seattle Genetics SGEN from Neutral to Underperform. The target price for Seattle Genetics has been lowered from $ $40 to $34. Seattle Genetics' shares closed at $38.39 yesterday.
Analysts at Brean Capital downgraded Endocyte ECYT from Buy to Hold. Endocyte's shares closed at $6.99 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in